Search

everythinglearnresearchcommunity

for

Search:↓

Touching hair can activate nearby nerve cells through signals from the hair's outer layer.

Four natural compounds were found to promote hair growth effectively.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

Human hair keratins K85 and K35 create unique filament patterns important for early hair formation.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The new skin patch with human matrix and antibiotic improves wound healing.

Keratin hydrogels from human hair show promise for tissue engineering and regenerative medicine.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Researchers developed a way to study human body clocks using hair tissue, which works similarly in both healthy and dementia patients.

Lhx2 is a crucial regulator of the Sonic Hedgehog signaling in early mouse retinal development.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

Chitosan scaffolds with silver nanoparticles effectively treat infected wounds and promote faster healing.

Polyurethane dressings show promise for wound healing but need improvements to adapt better to the healing process.

New synthetic polymers help improve skin wound healing and can be enhanced by adding natural materials and medicines.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

More kenogen hairs cause hair thinning in androgenetic alopecia, not hair miniaturization.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Researchers found several compounds that could potentially treat Zika virus.

Key genes linked to hair growth and cancer were identified in hairless mice.

NIH dermatology funding increased by 14.7% from 2015 to 2019, but men and certain states and institutions received most of the money.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.